Alexandra V. Eberhard, PhD MBA, is the Managing Director EMEA and President Healthcare/Life Sciences for Signals Analytics. She joined the team eight years ago and is one of the Signals Analytics pioneers. She has strongly contributed to the software solution development and its successful commercialization. For the last two years, Alexandra has played an integral role in the establishment and development of Signals overall growth strategy and success within the European market. Globally, her mission is to help healthcare & life sciences leaders drive product innovation and market growth.

Since 2009, Alexandra has also held the role of Partner for the leading investment house ‘Cukierman & Co Life Sciences’ (Israel). Here she supports business development, fundraising, licensing and M&A activities within the Group. Previously, she served as CEO of the biotech Recogene within ‘RAD BioMed Accelerator’ (Israel) and Associate Partner of the boutique consulting firm, ‘Quilt Solutions’ (Switzerland).

Dr V. Eberhard earned her PhD in Immunology/Virology at bioMerieux (France) and her post-doctorate at the Weizmann Institute of Science (Israel). She has co-authored more than 15 peer-reviewed international publications, disseminated her work at more than 20 top international conferences and received six academic awards. Dr V. Eberhard also earned an International MBA from Bar Ilan University (Israel).